Search Results 81-90 of 18011 for B cell lymphomas

  1. Study of Nivolumab in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL) That Have Either Failed or Are Not Eligible for Autologous Stem Cell Transplant (CheckMate 139) - Mayo Clinic

    Study of Nivolumab in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL) That Have Either Failed or Are Not Eligible for Autologous Stem ...

  2. Publications - Thomas M. Habermann, M.D. - Mayo Clinic

    Evaluation of Etiologic Heterogeneity for Risk of Diffuse Large B-Cell Lymphoma Subtype Defined by Cell-of-Origin. ... B-cell lymphomas. Blood Cancer J. 2024 Oct ...

  3. A Study of Durvalumab in Combination With R-CHOP or Lenalidomide Plus R-CHOP in Previously Untreated High-Risk Diffuse Large B-Cell Lymphoma - Mayo Clinic

    CD20+Diffuse Large B-Cell Lymphoma. · Ann Arbor stage 3 or 4 or stage 2 with bulky disease · High or high-intermediate disease risk. · No prior anti-lymphoma ...

  4. About CAR-T cell therapy - Mayo Clinic

    Aggressive B-cell lymphoma not otherwise specified (NOS); Mantle cell lymphoma; Follicular lymphoma; Multiple myeloma. People who have relapsed or refractory ...

  5. Efficacy and Safety Study of Lenalidomide Plus R-CHOP Chemotherapy Versus Placebo Plus R-CHOP Chemotherapy in Untreated ABC Type Diffuse Large B-cell Lymphoma - Mayo Clinic

    Efficacy and Safety Study of Lenalidomide Plus R-CHOP Chemotherapy Versus Placebo Plus R-CHOP Chemotherapy in Untreated ABC Type Diffuse Large B-cell Lymphoma.

  6. Avelumab In Combination Regimens That Include An Immune Agonist, Epigenetic Modulator, CD20 Antagonist and/or Conventional Chemotherapy in Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma (R/R DLBCL) - Mayo Clinic

    ... B-cell Lymphoma (R/R DLBCL). Print details. Share; Facebook · Twitter. Overview; Participation eligibility; Participating Mayo Clinic info; More information ...

  7. Hairy cell leukemia - Symptoms and causes - Mayo Clinic

    The white blood cells involved in hairy cell leukemia are called B cells. B ... The other cancers include non-Hodgkin's lymphoma, Hodgkin's lymphoma and others.

  8. Combination Chemotherapy With or Without Rituximab in Treating Younger Patients With Stage III-IV Non-Hodgkin Lymphoma or B-Cell Acute Leukemia - Mayo Clinic

    ... lymphoma or B-cell acute leukemia. Drugs used in chemotherapy work in different ways to stop the growth of cancer cells, either by killing the cells, by ...

  9. Treatment

    Cutaneous B-cell lymphoma treatment depends on the specific type of lymphoma that you have. Treatment options may include: Radiation therapy. Radiation ...

  10. A Trial to Evaluate the Efficacy and Safety of MOR208 With Bendamustine (BEN) Versus Rituximab (RTX) With BEN in Adult Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma (DLBCL) - Mayo Clinic

    ... B-cell Lymphoma (DLBCL). Print details. Share; Facebook · Twitter. Overview ... RTX and BEN are both approved in many countries for the treatment of lymphomas.